Antiretroviral Therapy for Prevention of HIV Infection: New Clues From an Animal Model


article has not abstract


Vyšlo v časopise: Antiretroviral Therapy for Prevention of HIV Infection: New Clues From an Animal Model. PLoS Med 5(2): e30. doi:10.1371/journal.pmed.0050030
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.0050030

Souhrn

article has not abstract


Zdroje

1. PalellaFJJrDelaneyKMMoormanACLovelessMOFuhrerJ

1998

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

N Engl J Med

338

853

860

2. CardoDMCulverDHCiesielskiCASrivastavaPUMarcusR

1997

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

N Engl J Med

337

1485

1490

3. CohenMSGayCKashubaADBlowerSPaxtonL

2007

Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1.

Ann Intern Med

146

591

601

4. FowlerMGLampeMAJamiesonDJKourtisAPRogersMF

2007

Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions.

Am J Obstet Gynecol

197

S3

S9

5. OttenRAAdamsDRKimCNJacksonEPulliumJK

2005

Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates.

J Infect Dis

191

164

173

6. SubbaraoSOttenRARamosAKimCJacksonE

2006

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.

J Infect Dis

194

904

911

7. García-LermaJGOttenRAQariSHJacksonECongM

2008

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.

PLoS Med

5

e28

doi:10.1371/journal.pmed.0050028

8. BrenchleyJMSchackerTWRuffLEPriceDATaylorJH

2004

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

J Exp Med

200

749

759

9. BoothCLGerettiAM

2007

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.

J Antimicrob Chemother

59

1047

1056

10. FerradiniLJeanninAPinogesLIzopetJOdhiamboD

2006

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

Lancet

367

1335

1342

11. BrennerBGOliveiraMDoualla-BellFMoisiDDNtemgwaM

2006

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture.

AIDS

20

F9

F13

12. Gilead Sciences

2007

Truvada package insert. 21-752-GS-20.

Available: http://www.gilead.com/pdf/truvada_pi.pdf. Accessed 3 January 2008

13. WangLHBegleyJSt ClaireRL3rdHarrisJWakefordC

2004

Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection.

AIDS Res Hum Retroviruses

20

1173

1182

14. HawkinsTVeikleyWSt ClaireRL3rdGuyerBClarkN

2005

Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens.

J Acquir Immune Defic Syndr

39

406

411

15. KingTBushmanLKiserJAndersonPLRayM

2006

Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells.

J Chromatogr B Analyt Technol Biomed Life Sci

843

147

156

16. Van RompayKKBrignoloLLMeyerDJJeromeCTararaR

2004

Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy) propyl]adenine (tenofovir) to newborn and infant rhesus macaques.

Antimicrob Agents Chemother

48

1469

1487

17. AbbasULAndersonRMMellorsJW

2007

Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings.

PLoS ONE

2

e875

doi:10.1371/journal.pone.0000875

18. GrantRMBuchbinderSCatesWJrClarkeECoatesT

2005

AIDS. Promote HIV chemoprophylaxis research, don't prevent it.

Science

309

2170

2171

19. PetersonLTaylorDRoddyRBelaiGPhillipsP

2007

Tenofovir disoproxil fumarate for prevention of HIV infection in women: A phase 2, double-blind, randomized, placebo-controlled trial.

PLOS Clin Trial

2

e27

doi:10.1371/journal.pctr.0020027

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2008 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa